In Conversation

Morocco Pharma Report 2020
Latest Reports
Morocco Pharma Report 2020
- 2020
Somewhat of a bastion of openness, predictability, and stability in a region often mired with turmoil, volatility, and economic nationalism, Morocco is increasingly attracting the attention of international investors across a range of industries. Nowhere is this more apparent than in the life sciences, where companies are taking note of the country’s strong business fundamentals, solid financial system, international-standard manufacturing, skilled human capital, and reputable legal framework.   Though not an enormous domestic pharma market at USD 1.6 billion, Morocco’s position at the crossroads between Europe and Africa is becoming ever more attracting as a base for international firms…
UAE Pharma Report April 2020
Latest Reports
UAE Pharma Report April 2020
- 2020
The UAE’s pharma market was predicted to grow to USD four billion in 2020, representing a CAGR of 8.5 percent from 2019. The country sits at the heart of the Middle East which, although only making up two percent of the global pharmaceutical industry, has been growing at a rate of ten percent and is therefore increasingly attracting the eye of international investors. With the full fallout of the global coronavirus pandemic still unknown as of April 2020, the UAE nevertheless seems set to remain a highly sought-after investment destination for the foreseeable future. A raft of multinational pharma…
Egypt Pharma Report July 2019
Latest Reports
Egypt Pharma Report July 2019
- 2019
Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations in its region.   Nowhere is this trend more apparent than in healthcare. With the launch of the Universal Healthcare Act, which aims to provide health coverage to all of Egypt’s 98 million inhabitants, as well as various national campaigns aimed at eradicating diseases such as Hepatitis C, healthcare and life sciences firms are increasingly cognizant of the abundant opportunities that Egypt has to offer.   Topics covered in…
Turkey Pharma Report 2019
Latest Reports
Turkey Pharma Report 2019
- 2019
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its neighbours – stands as one of the most promising healthcare and life science investment destinations in its region. Topics covered in this report range from the successes of Turkey’s Healthcare Transformation Programme (HTP), which has skyrocketed the level of the country’s healthcare system in little over a decade, the ongoing debate around reimbursement, and a localization policy to which multinational companies are having to adapt. Other hot-button issues touched upon include Turkey’s standing as the world’s…
Algeria Pharma Report 2019
Latest Reports
Algeria Pharma Report 2019
- 2019
Topics covered in this report – which features the exclusive insights of government ministers, the heads of local pharma champions as well as multinational affiliate leaders – include the potential impact of Algeria's sweeping new healthcare law, the establishment of the country's first National Cancer Plan, global companies’ scramble to localise manufacturing operations, an investment wave from the Middle East, and Algeria’s ramped-up export capabilities.
Tunisia Pharma Report
Latest Reports
Tunisia Pharma Report
- 2017
Transitioning out of a period of instability following the revolution of 2011, Tunisia has much to recommend it within its region. Comparative political stability and a geostrategic location as the northerly most country in Africa are helping turn the Arab world’s only full democracy into an attractive investment destination once again.   In terms of healthcare and the life sciences, Tunisia can boast impressive levels of medical tourism; a much-improved market access environment for innovative drugs; a historic and well-established pharmaceutical manufacturing footprint and therefore the potential to export in larger volumes to its neighbors; as well as the…
Egypt Pharma Report
Latest Reports
Egypt Pharma Report
- 2016
This report offers companies, investors, policymakers, and stakeholders crucial insight into the largest pharmaceutical manufacturing base and the second largest pharmaceuticals market by value in the Middle East. Despite recent political upheaval, Egypt is a key growth market with massive unmet needs and huge potential for potential investors.The report features a foreword from President Abdel Fattah El-Sisi, as well as an in-depth interview with Minister of Health Ahmed Emad El Din Rady. It also includes interview with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors.…
South Africa Pharma Report
Latest Reports
South Africa Pharma Report
- 2016
This report is an authoritative assessment of the South African healthcare and pharma markets. It features an exclusive in-depth interview with Dr. Aaron Motsoaledi, South African Minister of Health, as well as with leading figures from both public institutions and private companies. Also included are up-to-date facts and figures on South Africa’s healthcare and pharma sectors.
Mauritius Pharma Report
Latest Reports
Mauritius Pharma Report
- 2016
Mauritius is in the process of rebranding itself as a business-friendly, technologically advanced hub for the pharma industry that will act as a bridge between Asia and Africa. This report offers companies, investors, policymakers, and stakeholders crucial insight into this thriving, vibrant country and market. It features an exclusive in-depth interview with the President of Mauritius, Ameenah Gurib-Fakim, as well as interviews with senior executives from the island’s major companies and leaders of its most important institutions. The report also contains updated facts and figures on Mauritius’s healthcare and pharma sectors.
Turkey Pharma Sector Industry Report
Latest Reports
Turkey Pharma Sector Industry Report
- 2016
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the Turkish pharmaceutical industry; an industry with a rich heritage currently striving to find the balance between fostering domestic growth and building stronger international partnerships. It features interviews with senior executives from the major companies in Turkey and leaders of the country’s most important institutions, updated facts and figures on Turkey’s healthcare and pharma sectors, and an exclusive in-depth cover story, ‘Navigating the Crossroads’.  

Focus on Turkey

Read more from Turkey >>

Focus on UAE

Read more from UAE >>

Focus on Saudi Arabia

Read more from Saudi Arabia >>

Focus on Egypt

Read more from Egypt >>

We use cookies to ensure that we give you the best experience on our site. For more info click here